Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,920 | 65,064 | 90,030 | 139,065 | 123,436 |
| Marketable Securities | 174,374 | 281,337 | 408,166 | 213,996 | 564,833 |
| Receivables | 41,731 | 37,969 | 40,057 | 17,409 | 10,047 |
| Inventories | 8,440 | 14,448 | 14,453 | 19,263 | 14,063 |
| TOTAL | $283,752 | $410,188 | $562,146 | $402,748 | $726,914 |
| Non-Current Assets | |||||
| PPE Net | 48,616 | 68,227 | 83,447 | 85,262 | 39,692 |
| Investments And Advances | 33,660 | 0 | 0 | 217,145 | 118,525 |
| Intangibles | 122,397 | 124,100 | 125,799 | 127,498 | 129,197 |
| Other Non-Current Assets | 50,951 | 58,619 | 85,225 | 90,691 | 102,086 |
| TOTAL | $255,624 | $250,946 | $294,471 | $520,596 | $389,500 |
| Total Assets | $539,376 | $661,134 | $856,617 | $923,344 | $1,116,414 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,265 | 7,719 | 8,084 | 3,307 | 3,237 |
| Accrued Expenses | 23,995 | 22,282 | 28,359 | 24,985 | 25,112 |
| Other current liabilities | 865 | N/A | N/A | N/A | N/A |
| TOTAL | $98,053 | $88,015 | $109,788 | $113,807 | $105,197 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 55,689 | 48,630 | 64,115 | 80,460 | 73,319 |
| Other Non-Current Liabilities | 211,685 | 220,102 | 224,309 | 106,704 | 104,333 |
| TOTAL | $238,838 | $264,841 | $282,731 | $205,435 | $267,951 |
| Total Liabilities | $336,891 | $352,856 | $392,519 | $319,242 | $373,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 148,582 | 145,092 | 143,227 | 141,584 | 139,220 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -1,303,824 | -1,144,332 | -919,082 | -718,891 | -511,612 |
| Other shareholders' equity | -58 | 94 | -4,183 | -1,027 | 893 |
| TOTAL | $202,485 | $308,278 | $464,098 | $604,102 | $743,266 |
| Total Liabilities And Equity | $539,376 | $661,134 | $856,617 | $923,344 | $1,116,414 |